PubMed for id: 890733

Year	Number of Results
2014	3
2015	2
2016	1
2017	2
2018	6
2019	2
2020	6
2021	3
2022	9
2023	11
2024	2

1

Pediatric spindle cell/sclerosing rhabdomyosarcoma with FUS-TFCP2 fusion: a case report and literature review.

Fang Z, Duan C, Wang S, Fu L, Yang P, Yu T, Deel MD, Lau LMS, Ma X, Ni X, Su Y. Fang Z, et al. Transl Pediatr. 2024 Jan 29;13(1):178-191. doi: 10.21037/tp-23-603. Epub 2024 Jan 24. Transl Pediatr. 2024. PMID: 38323177 Free PMC article.

2

Multifaceted Spindle Cell/Sclerosing Rhabdomyosarcoma With Role of Immunohistochemistry in Avoiding Misdiagnosis: A Multi-Institutional Study of 45 Distinct Tumors.

Jain E, Munjal G, Sharma S, Brar Z, Bhardwaj N, Dewan A, Jain D, Jha S, Lobo A, Malik V, Arora S, Varshney J, Beg A, Sampat NY, Parwani AV, Balzer B, Varma M, Yadav BS, Sharma SK, Singh HP, Gogoi K, Kumar D, Bhandari V, Fulara LM, Kumar A, Singh H, Bhattacharya M, Dixit M, Mohanty SK. Jain E, et al. Int J Surg Pathol. 2024 May;32(3):496-506. doi: 10.1177/10668969231188422. Epub 2023 Jul 25. Int J Surg Pathol. 2024. PMID: 37489265

3

Oral spindle cell/sclerosing rhabdomyosarcoma on mandible with anaplastic lymphoma kinase expression mimicking inflammatory myofibroblastic tumor.

Lee JY, Lee W, Kim MY. Lee JY, et al. J Korean Assoc Oral Maxillofac Surg. 2023 Apr 30;49(2):96-99. doi: 10.5125/jkaoms.2023.49.2.96. J Korean Assoc Oral Maxillofac Surg. 2023. PMID: 37114448 Free PMC article.

4

Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result.

Rekhi B, Dodd L, Dharavath B, Dutt A. Rekhi B, et al. Diagn Cytopathol. 2022 Dec;50(12):E367-E372. doi: 10.1002/dc.25032. Epub 2022 Aug 5. Diagn Cytopathol. 2022. PMID: 35929754

5

Spindle Cell/Sclerosing Rhabdomyosarcoma of the Orbit.

Proia AD. Proia AD. Ophthalmic Plast Reconstr Surg. 2023 Jan-Feb 01;39(1):e17-e20. doi: 10.1097/IOP.0000000000002252. Epub 2022 Jul 13. Ophthalmic Plast Reconstr Surg. 2023. PMID: 35829629

6

Spindle Cell/Sclerosing Rhabdomyosarcoma With PAX8::PPARG Fusion.

Rakheja D, Park JY, Alhasan M, Uddin N. Rakheja D, et al. Int J Surg Pathol. 2022 Dec;30(8):950-955. doi: 10.1177/10668969221095170. Epub 2022 Apr 24. Int J Surg Pathol. 2022. PMID: 35466752

7

Spindle cell/sclerosing rhabdomyosarcoma with DCTN1::ALK fusion: broadening the molecular spectrum with potential therapeutic implications.

Fung CK, Chow C, Chan WK, Choi EWK, To KF, Chan JKC, Cheuk W. Fung CK, et al. Virchows Arch. 2022 Apr;480(4):927-932. doi: 10.1007/s00428-022-03305-8. Epub 2022 Mar 1. Virchows Arch. 2022. PMID: 35229187

8

Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma.

Tsuchiya R, Yoshimatsu Y, Noguchi R, Sin Y, Ono T, Sei A, Takeshita F, Sugaya J, Nakatani F, Yoshida A, Ohtori S, Kawai A, Kondo T. Tsuchiya R, et al. Hum Cell. 2021 Sep;34(5):1569-1578. doi: 10.1007/s13577-021-00569-1. Epub 2021 Jun 23. Hum Cell. 2021. PMID: 34164773

9

Challenges in the Diagnosis of Pediatric Spindle Cell/Sclerosing Rhabdomyosarcoma.

Chen S, Rudzinski ER, Arnold MA. Chen S, et al. Surg Pathol Clin. 2020 Dec;13(4):729-738. doi: 10.1016/j.path.2020.08.010. Epub 2020 Oct 9. Surg Pathol Clin. 2020. PMID: 33183730 Review.

10

Establishment and characterization of NCC-ssRMS1-C1: a novel patient-derived spindle-cell/sclerosing rhabdomyosarcoma cell line.

Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Sugaya J, Iwata S, Sugiyama M, Yoshida A, Kawai A, Kondo T. Yoshimatsu Y, et al. Hum Cell. 2020 Jul;33(3):886-893. doi: 10.1007/s13577-020-00359-1. Epub 2020 Apr 16. Hum Cell. 2020. PMID: 32300959

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

41 results

Results by year